EMERGENT BIOSOLUT (ER4 BE) stock market data APIs
€10.2549
0(0%)
as of February 12, 2026
Try our APIs with
free plan!
EMERGENT BIOSOLUT Financial Data Overview
Price chart is built with
Anychart
There is no Profile data available for ER4.BE.
Prev. Close
10.2549
Open
10.2549
High
10.2549
Low
10.2549
52 wk Range
3.77-11.11
Market Cap
1 908 M
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get EMERGENT BIOSOLUT data using free add-ons & libraries
Get EMERGENT BIOSOLUT Fundamental Data
EMERGENT BIOSOLUT Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
EMERGENT BIOSOLUT News
New
NY Attorney General Sues Former Emergent BioSolutions CEO for Insider Trading
Letitia James accused Robert Kramer of selling his shares in Emergent before disclosing contamination issues in its production of the Covid-19 vaccine. Continue Reading
Emergent BioSolutions' Former CEO Sued for Insider Trading by New York Attorney General
Emergent BioSolutions (EBS) former CEO Robert Kramer was sued by New York Attorney General Letitia J PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscri...
Emergent BioSolutions Receives U.S. FDA Approval on Supplemental New Drug Application for NARCAN® Nasal Spray to be Packaged in a New Carrying Case, Making Life-Saving Naloxone More Accessible for Everyday Preparedness
Emergent BioSolutions Since the U.S. prescription launch of NARCAN® Nasal Spray in 2016, the medicine has been trusted as a safe, effective way to reverse opioid overdoses, and today, new solutions ...
Emergent BioSolutions Announces $100 Million Paydown of Term Loan Principal, a Significant Step Achieved Toward its Multi-year Transformation
Emergent BioSolutions GAITHERSBURG, Md., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Today Emergent BioSolutions, Inc. (NYSE: EBS) announced it made a voluntary prepayment of $100 million under its outstanding...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
